Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis
Clinical trial NCT01828086 · COMPLETED
Trial details
- NCT number
- NCT01828086
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.